Literature DB >> 11053087

Update on D2E7: a fully human anti-tumour necrosis factor alpha monoclonal antibody.

J Kempeni1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2000        PMID： 11053087      PMCID： PMC1766613          DOI： 10.1136/ard.59.suppl_1.i44

Source DB:  PubMed          Journal:  Ann Rheum Dis        ISSN： 0003-4967            Impact factor:   19.103


× No keyword cloud information.
  8 in total

Review 1.  Preliminary results of early clinical trials with the fully human anti-TNFalpha monoclonal antibody D2E7.

Authors:  J Kempeni
Journal:  Ann Rheum Dis       Date:  1999-11       Impact factor: 19.103

Review 2.  Clinical management of rheumatoid arthritis.

Authors:  P M Brooks
Journal:  Lancet       Date:  1993-01-30       Impact factor: 79.321

Review 3.  The links between joint damage and disability in rheumatoid arthritis.

Authors:  D L Scott; K Pugner; K Kaarela; D V Doyle; A Woolf; J Holmes; K Hieke
Journal:  Rheumatology (Oxford)       Date:  2000-02       Impact factor: 7.580

Review 4.  Cytokine blockade as a new strategy to treat rheumatoid arthritis: inhibition of tumor necrosis factor.

Authors:  D A Fox
Journal:  Arch Intern Med       Date:  2000-02-28

5.  Matrix metalloproteinases, but not cathepsins B, H, and L or their inhibitors in peripheral blood of patients with rheumatoid arthritis are potentially useful markers of disease activity.

Authors:  G Keyszer; I Lambiri; M Keysser; C Keysser; R Nagel; G R Burmester; K Jung
Journal:  Z Rheumatol       Date:  1998-12       Impact factor: 1.372

Review 6.  Anti-tumor necrosis factor-alpha monoclonal antibody therapy for rheumatoid arthritis.

Authors:  A F Kavanaugh
Journal:  Rheum Dis Clin North Am       Date:  1998-08       Impact factor: 2.670

Review 7.  TNF-alpha in rheumatoid arthritis and prospects of anti-TNF therapy.

Authors:  R N Maini; F M Brennan; R Williams; C Q Chu; A P Cope; D Gibbons; M Elliott; M Feldmann
Journal:  Clin Exp Rheumatol       Date:  1993 Mar-Apr       Impact factor: 4.473

Review 8.  Mechanisms of action of the tumor necrosis factor and lymphotoxin ligand-receptor system.

Authors:  K Warzocha; J Bienvenu; B Coiffier; G Salles
Journal:  Eur Cytokine Netw       Date:  1995 Mar-Apr       Impact factor: 2.737
  8 in total
  3 in total

1.  Chlamydia trachomatis-infected macrophages induce apoptosis of activated T cells by secretion of tumor necrosis factor-alpha in vitro.

Authors:  Michael C Jendro; Frederik Fingerle; Tobias Deutsch; Andrea Liese; Lars Köhler; Jens G Kuipers; Elke Raum; Michael Martin; Henning Zeidler
Journal:  Med Microbiol Immunol       Date:  2003-05-15       Impact factor: 3.402

2.  Scintigraphic detection of tumour necrosis factor in patients with rheumatoid arthritis.

Authors:  P Barrera; W J G Oyen; O C Boerman; P L C M van Riel
Journal:  Ann Rheum Dis       Date:  2003-09       Impact factor: 19.103

3.  RAPID: A Rep-Seq Dataset Analysis Platform With an Integrated Antibody Database.

Authors:  Yanfang Zhang; Tianjian Chen; Huikun Zeng; Xiujia Yang; Qingxian Xu; Yanxia Zhang; Yuan Chen; Minhui Wang; Yan Zhu; Chunhong Lan; Qilong Wang; Haipei Tang; Yan Zhang; Chengrui Wang; Wenxi Xie; Cuiyu Ma; Junjie Guan; Shixin Guo; Sen Chen; Wei Yang; Lai Wei; Jian Ren; Xueqing Yu; Zhenhai Zhang
Journal:  Front Immunol       Date:  2021-08-13       Impact factor: 7.561
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.